Abstract
POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) is a plasma cell dyscrasia that differs substantially from classic multiple myeloma. It is often associated with disabling polyneuropathy in younger patients. Current therapeutic approaches are frequently inadequate and leave many patients wheelchair-bound with significant deterioration in quality and length of life. We present the case of a young man with progressive disease despite conventional therapeutic approaches. We describe a novel approach to treatment with a bone-seeking radiopharmaceutical, samarium-153 ethylene diamine tetramethylene phosphonate (153Sm-EDTMP), followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell reconstitution. This approach resulted in regression of the organomegaly and skin changes and in neurologic improvement both clinically and electrophysiologically. The patient progressed from being wheelchair-bound to independent ambulation. An aggressive approach should be considered in patients with POEMS syndrome in whom standard therapeutic measures fail. Bone Marrow Transplantation (2001) 28, 305–309.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bardwick PA, Zvaifler NJ, Gill GN et al. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature Medicine (Balt) 1980 59: 311–322
Nakanishi T, Sobue I, Toyokura Y et al. The Crow–Fukase syndrome: a study of 102 cases in Japan Neurology 1984 34: 712–720
Miralles GD, O'Fallon JR, Talley NJ . Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome New Engl J Med 1992 327: 1919–1923
Lee GR, Foerster J, Lukens J et al. Wintrobe's Clinical Hematology tenth edn, vol. 2 Williams & Wilkins: Baltimore 1999
Hitoshi S, Suzuki K, Sakuta M . Elevated serum interleukin-6 in POEMS syndrome reflects the activity of the disease Intern Med 1994 33: 583–587
Soubrier M, Dubost JJ, Serre AF et al. Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor Arthr Rheum 1997 40: 786–787
Gherardi RK, Belec L, Soubrier M et al. Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome Blood 1996 87: 1458–1465
Watanabe O, Arimura K, Kitajima I et al. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome (letter) Lancet 1996 347: 702
McEwan AJ . Unsealed source therapy of painful bone metastases: an update Semin Nucl Med 1997 27: 165–182
Ahonen A, Joensuu H, Hiltunen J et al. Samarium-153-EDTMP in bone metastases J Nucl Biol Med 1994 38: 123–127
Tian JH, Zhang JM, Hou QT et al. Multicentre trial on the efficacy and toxicity of single-dose samarium-153-ethylene diamine tetramethylene phosphonate as a palliative treatment for painful skeletal metastases in China Eur J Nucl Med 1999 26: 2–7
Turner JH, Claringbold PG, Manning LS et al. Radiopharmaceutical therapy of 5T33 murine myeloma by sequential treatment with samarium-153 ethylenediaminetetramethylenephosphonate, melphalan, and bone marrow transplantation J Natl Cancer Inst 1993 85: 1508–1513
Comenzo RL, Vosburgh E, Falk RH et al. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients Blood 1998 91: 3662–3670
Moreau P, Milpied N, de Faucal P et al. High-dose melphalan and autologous bone marrow transplantation for systemic AL amyloidosis with cardiac involvement (letter) Blood 1996 87: 3063–3064
van Buren M, Hene RJ, Verdonck LF et al. Clinical remission after syngeneic bone marrow transplantation in a patient with AL amyloidosis Ann Intern Med 1995 122: 508–510
Comenzo RL . American Society of Hematology Education Program Book High-Dose Therapy for the Treatment of Primary Systemic Amyloidosis American Society of Hematology: New Orleans 1999 pp 347–357
Gertz MA, Lacy MQ, Inwards DJ et al. Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma Bone Marrow Transplant 1999 23: 221–226
Alegre A, Diaz-Mediavilla J, San-Miguel J et al. Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Espanol de Trasplante Hematopoyetico-GETH) and PETHEMA Bone Marrow Transplant 1998 21: 133–140
Turner JH, Claringbold PG, Manning LS, O'Donoghue HL, Berger JD, Glancy RJ . Radiopharmaceutical therapy of 5T33 murine myeloma by sequential treatment with samarium-153 ethylenediaminetetramethylene phosphonate, melphalan, and bone marrow transplantation J Natl Cancer Inst 1993 15: 1508–1513
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hogan, W., Lacy, M., Wiseman, G. et al. Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation. Bone Marrow Transplant 28, 305–309 (2001). https://doi.org/10.1038/sj.bmt.1703108
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703108
Keywords
This article is cited by
-
Poems syndrome: consolidation with autologous stem cell transplantation
Bone Marrow Transplantation (2021)
-
POEMS Syndrome: an Enigma
Current Hematologic Malignancy Reports (2017)
-
Durable responses with autologous hematopoietic SCT in patients with POEMS syndrome
Bone Marrow Transplantation (2014)
-
Serial renal biopsy findings in a case of POEMS syndrome with recurrent acute renal failure
Clinical and Experimental Nephrology (2012)
-
Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome (MCD-POEMS variant)
Annals of Hematology (2010)